theCPC.org

The CPC.org Blog

Meaningful photos, videos, and stories.

CBD Administration Associated With Improved Quality Of Life In Patients With Parkinson’s Disease


The following is a piece for the NORML blog by NORML Deputy Director Paul Armentano, September 25, 2014. See original piece here.


The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, is associated with improved quality of life in patients with Parkinson’s disease, according clinical trial data published online ahead of print in the Journal of Psychopharmacology.


 

Journal of Pharmacolofy CBD Quality of Life Parkinsons


Investigators at the University of São Paulo in Brazil assessed the efficacy of CBD versus placebo in 21 subjects with Parkinson’s. Authors reported that the administration of 300 mg doses of CBD per day was associated with “significantly different mean total scores” in subjects’ well-being and quality of life compared to placebo.

Separate assessments of CBD versus placebo reported that the cannabinoid did not appear to mitigate general symptoms of the disease, nor was it shown to be neuroprotective.


 

"Two roads diverged in a wood, and I took the one less traveled by, and that has made all the difference." Robert Frost


“This study points to a possible effect of CBD in improving measures related to the quality of life of PD patients without psychiatric comorbidities,” investigators concluded. They added, “We found no statistically significant differences concerning the motor symptoms of PD; however, studies involving larger samples and with systematic assessment of specific symptoms of PD are necessary in order to provide stronger conclusions regarding the action of CBD in PD.”

Clinical reports have previously indicated that both CBD and/or whole-plant cannabis may address various symptom’s of Parkinson’s disease, including improvement in motor symptoms, pain reduction, improved sleep, and a reduction in the severity of psychotic episodes.

Survey data of patients with PD indicates that almost half of all subjects who try cannabis report experiencing subjective relief from the plant.

The abstract of the study, “Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial,” appears online here.

- See more at: http://blog.norml.org/2014/09/25/study-cbd-administration-associated-with-improved-quality-of-life-in-patients-with-parkinsons-disease/#sthash.nBICGOsq.dpuf